Inventor

Hossein Razavi

Inventor
Danbury, CT, US

Overview

24→
Patents
2005–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,889,568Inhibitors of TRPC6202110,800,757Inhibitors of TRPC6202010,138,222Substituted benzamides as RIPK2 inhibitors20189,573,957'Inhibitors of leukotriene production'20179,403,830'Inhibitors of leukotriene production'20169,056,858'Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists'20158,946,203'Benzodioxane inhibitors of leukotriene production'20158,741,897'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof'20148,658,637'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof'20148,653,119'Methods for treating transthyretin amyloid diseases'20148,546,442'Pyrazolopiperidine compounds as CCR1 receptor antagonists'20138,338,610'Pyridinyl compounds useful as intermediates'20128,293,917'Pyrazole compounds as CCR1 antagonists'20128,268,859'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof'20128,212,040'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof'20128,168,663'Pharmaceutically acceptable salt of 6-carboxy-2-(3,5 dichlorophenyl)-benzoxazole, and a pharmaceutical composition comprising the salt thereof'20128,063,065'Azaindazole compounds as CCR1 receptor antagonists'20118,008,327'Indazole compounds as CCR1 receptor antagonists'20117,879,873'Azaindazole compounds as CCR1 receptor antagonists'20117,553,966'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20097,268,152'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20077,214,695'Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding'20077,074,806'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'20066,903,215'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2014Patents assigned to BOEHRINGER INGELHEIM PHARMA (6)· patent assignee history
2005–2021Based in Danbury, CT, US· patent location history
2011–2021Patents assigned to BOEHRINGER INGELHEIM INT (15)· patent assignee history
2011–2017Patents assigned to RAZAVI HOSSEIN (14)· patent assignee history
2011–2015Patents assigned to KUZMICH DANIEL (8)· patent assignee history
2011–2014Patents assigned to LIU PINGRONG (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOEHRINGER INGELHEIM INT152011–2021
RAZAVI HOSSEINself142011–2017
KUZMICH DANIEL82011–2015
BOEHRINGER INGELHEIM PHARMA62005–2014
LIU PINGRONG62011–2014
Locations
LocationPatentsSpan
Danbury, CT, US242005–2021